Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TMP-SMX plus Rifampicin vs Linezolid for MRSA Infections
NCT00711854Phase 4Completed
- Start
- Jan 2009
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of trimethoprim + sulfamethoxazole, rifampicin in Staphylococcus aureus infection. Started Jan 2009; status: completed.
02
Drugs
trimethoprim + sulfamethoxazolerifampicin
03
Conditions
Staphylococcus aureus infection
Beyond the preview
Go deeper on NCT00711854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00711854.